WHO Guidelines & Disease Management
The World Health Organization has developed a comprehensive package of preconception care interventions to address global maternal and child health challenges. Combined with disease-specific protocols for conditions like sickle cell disease, diabetes, chronic kidney disease, and epilepsy, these guidelines provide a roadmap for optimizing health before pregnancy.
🌍 WHO Package of Preconception Care Interventions
The WHO has developed a comprehensive, evidence-based package of interventions designed to improve maternal and child health outcomes worldwide.
Core Intervention Categories
Nutritional Interventions
- Folic Acid: Supplementation to prevent neural tube defects
- Iron & Calcium: Address deficiencies and anemia
- Iodine: Prevent iodine deficiency disorders
- Balanced Diet: Achieve healthy weight and nutrition
Vaccination & Prevention
- Rubella: Prevent congenital rubella syndrome
- Tetanus: Maternal and neonatal tetanus prevention
- Hepatitis B: Reduce vertical transmission
- Influenza: Seasonal vaccination
Screening & Testing
- HIV/AIDS: Testing and treatment to prevent MTCT
- STIs: Screen and treat infections
- Chronic Diseases: Diabetes, hypertension screening
- Genetic Screening: Based on family history and ethnicity
Behavioral & Social
- Tobacco Cessation: Smoking and tobacco use
- Alcohol Avoidance: Complete abstinence recommended
- Violence Prevention: Screen for domestic violence
- Mental Health: Address depression and anxiety
Comprehensive Approach: The WHO package addresses biomedical, behavioral, and social determinants of maternal and child health.
🩸 Preconception Care in Sickle Cell Disease (SCD)
Women with SCD face unique challenges during pregnancy that require comprehensive preconception planning.
Impact of SCD on Pregnancy
Physiological Changes
- Increased metabolic demand
- Increased blood viscosity
- Hypercoagulability
- Higher risk of crises
Maternal Complications
- Vaso-occlusive crisis (increased incidence)
- Acute chest syndrome
- Osteonecrosis
- Hepatic necrosis and leg ulcers
- Thromboembolic events
Fetal Complications
- Placental vaso-occlusion
- Villous fibrosis and necrosis
- Impaired uteroplacental circulation
- Chronic fetal hypoxia
- Adverse fetal outcomes
Preconception Management in SCD
Medical History & Vaccination
- Complete medical and social history
- Vaccination status review
- Current medications assessment
- Screen for co-morbid conditions
- Assess for drug abuse
- Vaccines: Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae, Hepatitis B, Influenza
Supplementation & Screening
- Folic Acid: 5 mg once daily (preconception and throughout pregnancy)
- Iron Overload: Check ferritin levels
- Iron Chelation: Aggressive chelation if significantly iron loaded
- Iron Supplementation: Only if evidence of deficiency
Medication Adjustments
Discontinue 3 Months Before Conception:
- Hydroxyurea
- ACE (angiotensin-converting enzyme) inhibitors
- Iron chelators
Screening for Target Organ Complications
| System | Screening Method | Purpose |
|---|---|---|
| Pulmonary | Symptomatology screen / 2D echocardiography | Detect pulmonary hypertension |
| Ophthalmologic | Fundoscopy | Screen for proliferative retinopathy |
| Renal | BP, proteinuria, renal function | Identify/rule out sickle nephropathy |
| Hepatic | Liver function studies | Rule out deranged hepatic function |
Patient Education: Women should be advised on crisis avoidance (preventing dehydration, cold, over-exertion, stress, hypoxia, and infection) and have a low threshold for seeking medical help.
Partner Screening: Women should be made aware of the importance of partner screening and options for prenatal screening, including pre-implantation genetic testing.
💉 Preconception Care in Diabetes Mellitus
Pre-gestational diabetes requires meticulous preconception planning to minimize maternal and fetal risks.
Adverse Pregnancy Outcomes in Diabetes
Maternal Complications
- Diabetic nephropathy deterioration (twofold risk of progression)
- Diabetic retinopathy progression or new onset
- Autonomic neuropathy and gastroparesis worsening
- Three to fourfold increased risk of preeclampsia
- Increased risk of miscarriage with poor control
Fetal Complications
- Congenital abnormalities (related to peri-conception control)
- Macrosomia
- Intrauterine growth restriction
- Preterm delivery
- Stillbirth
Neonatal Complications
- Respiratory distress syndrome
- Hypoglycemia
- Hypocalcemia
- Polycythemia
- Hyperbilirubinemia
Pre-gestational Diabetes Management
Glycemic Control
- Target HbA1C: Less than 6.5% lowers risk of congenital abnormalities
- High-Risk Level: HbA1C greater than 10.6% confers 8× higher risk of birth defects
- Counseling: Good control lowers risk of preeclampsia
- Optimization: Achieve target before conception
Complications Assessment
- Evaluate hypertension status
- Assess nephropathy severity
- Screen for retinopathy
- Review autonomic neuropathy
- Optimize all complications before pregnancy
Contraindications to Pregnancy:
- Ischemic heart disease
- Untreated proliferative retinopathy
- Severe gastroparesis
- Severe renal impairment (CKD 4/5; creatinine greater than 250 μmol/L)
Pre-treatment: If necessary, proliferative retinopathy may be treated with photocoagulation prior to conception.
Essential Interventions
- Folic Acid: 5 mg per day supplementation
- Pre-pregnancy Counseling: Allows optimization of diabetic control and complications assessment
- Education: Risks and benefits discussion, improved pregnancy outcomes with good control
🫘 Preconception Care in Chronic Kidney Disease (CKD)
CKD poses significant challenges in pregnancy, requiring careful preconception assessment and planning.
Preconception Assessment
Baseline Evaluation
- Renal Function: Creatinine, GFR assessment
- Proteinuria: Quantify protein loss
- Blood Pressure: Establish control
- Purpose: Provides baseline for pregnancy comparison
Risk Stratification
- Severity of renal impairment assessment
- Increased risk of adverse outcomes with severe disease
- Higher risk of renal function decline
- Complications: preeclampsia, FGR, preterm delivery
Management Considerations
Severe Renal Impairment
- Consider surrogacy option
- Discuss risks thoroughly
- Joint decision-making
Preeclampsia Prevention
- Low-dose aspirin advised
- Especially with hypertension
- Previous poor obstetric history
Multidisciplinary Care
- Obstetricians with expertise
- Physicians specialized in renal disease
- Joint management approach
Antenatal Management Plan
- Regular blood pressure monitoring
- Serial renal function assessment
- Fetal well-being surveillance
- Early detection of complications
High-Risk Population: Women with more severe renal impairment require intensive monitoring and may need alternative reproductive options.
⚡ Preconception Counseling in Epilepsy
Women with epilepsy require specialized preconception counseling to optimize medication and reduce fetal risks.
General Preconception Advice
Lifestyle Modifications
- Stress and anxiety management
- Smoking cessation
- Alcohol consumption avoidance
- Balanced diet maintenance
- Regular sleep schedule
- Regular exercise routine
Safety Precautions
- Adherence to medication (despite concerns about fetal development)
- Avoid bathing or swimming alone
- Avoid climbing heights
- Seizure safety planning
Antiepileptic Drug (AED) Selection
| Medication | Teratogenic Risk | Considerations |
|---|---|---|
| Lamotrigine | Least teratogenic | Preferred option for pregnancy |
| Levetiracetam | Least teratogenic | Preferred option for pregnancy |
| Carbamazepine | Equivalent to lamotrigine/levetiracetam | Used less due to poor tolerability and enzyme-inducing effects |
| Valproic Acid | High teratogenic risk | Associated with neural tube defects, neurocognitive effects, craniofacial/limb/cardiac abnormalities |
Valproic Acid Risks:
- Neural tube defects
- Adverse neurocognitive effects
- Craniofacial abnormalities
- Limb abnormalities
- Cardiac abnormalities
Key Message: Women should be counseled that medication adherence is critical, and safer AED options should be considered before conception.
💰 Cost-Effectiveness of Preconception Care
Evidence from high-income countries demonstrates that preconception care is not only effective but also cost-saving.
Economic Evidence
High-Income Country Data
- Preconception care programs are effective
- Result in significant cost savings
- Initial costs balanced by savings from averted complications
- Long-term health benefits reduce future costs
USA Study: Diabetes
- Net Cost Saving: Approximately $34,000 per patient
- Less frequent hospitalization
- Shorter inpatient stays
- Shorter length of stay after delivery
- Lower intensity neonatal care
Mechanisms of Cost Savings
- Maternal: Significantly less frequent hospitalization and shorter inpatient stays
- Delivery: Shorter length of stay after delivery
- Neonatal: Lower intensity of care and shorter length of stay for infants
- Prevention: Averted complications reduce emergency and intensive care needs
Data Gap: Data on effectiveness, costs, and cost-effectiveness of programs in low and middle-income countries (LMICs) are not available.
🌐 Challenges in Low and Middle-Income Countries
LMICs face unique challenges in implementing comprehensive preconception care programs.
Key Challenges
Resource Constraints
- Limited healthcare infrastructure
- Financial constraints
- Competing health priorities
- Workforce shortages
Coverage Gaps
- Struggle to increase prenatal care coverage
- Low rates of skilled care at birth
- Limited access to specialized services
- Geographic barriers
Program Weaknesses
- Weak or nonexistent programs
- No guarantee of optimal health at conception
- Lack of standardized guidelines
- Limited awareness and education
Pragmatic Solutions
Targeted Approach
- Identify at-risk target groups
- Focus on women with chronic conditions
- Prioritize couples with previous adverse outcomes
- Concentrate resources where most needed
Feasible Interventions
- Deliver small number of effective interventions
- Based on feasibility and resources
- Use existing healthcare touchpoints
- Integrate with other MCH services
Immediate Solution: Countries should identify at-risk target groups and deliver a small number of effective interventions based on feasibility.
📋 Extending the MCH Package
Integrating preconception care into the maternal and child health (MCH) continuum strengthens the entire healthcare system.
Benefits of Extension
- Promotes good health before pregnancy
- Prevents health problems proactively
- Responds effectively to issues during pregnancy
- Creates seamless continuum of care
Implementation Strategy
- Integrate with existing MCH services
- Leverage family planning visits
- Use community health worker networks
- Build on existing infrastructure
Synergy: Countries that need preconception care most are likely to face both logistic and financial challenges, but integration with existing services can maximize efficiency.
🔬 Research and Development Needs
Significant research gaps exist, particularly regarding implementation in resource-limited settings.
Critical Research Priorities
- Effectiveness Studies: Evaluate outcomes of preconception interventions in LMIC contexts
- Cost Analysis: Determine actual costs of implementing programs in different settings
- Cost-Effectiveness: Calculate return on investment for LMIC health systems
- Implementation Science: Identify best delivery models for different contexts
- Feasibility Studies: Assess which interventions work best with limited resources
- Cultural Adaptation: Tailor interventions to local contexts and beliefs
Evidence Gap: While high-income country evidence is strong, LMIC-specific data is urgently needed to guide policy and practice.
🎯 Recommendations for Implementation
Practical steps can be taken now to improve preconception care delivery, even with limited resources.
Policy Level
- Develop national preconception care guidelines
- Include preconception care in MCH policies
- Allocate dedicated funding
- Establish quality standards
Health System Level
- Train healthcare providers
- Integrate into existing services
- Create referral pathways
- Monitor and evaluate outcomes
Community Level
- Raise awareness about preconception care
- Engage community health workers
- Address cultural barriers
- Promote male involvement
🧠 Key Takeaways
- WHO provides comprehensive package addressing nutrition, vaccination, screening, and behavioral factors
- SCD requires vaccination updates, folic acid 5 mg, and target organ screening before conception
- Diabetes preconception care aims for HbA1C less than 6.5% to minimize birth defect risk
- CKD needs baseline renal assessment and multidisciplinary management approach
- Epilepsy management favors lamotrigine or levetiracetam; avoid valproic acid
- Preconception care is highly cost-effective with substantial long-term savings
- LMICs face resource and implementation challenges requiring targeted approaches
- Current practice often delays interventions until after conception has occurred
- Local and national guidelines are essential for systematic implementation
- Integration with existing MCH services can improve feasibility and coverage
🧭 Conclusion
The WHO package of preconception care interventions, combined with disease-specific protocols, provides a comprehensive framework for optimizing maternal and child health outcomes. While evidence from high-income countries demonstrates both effectiveness and cost-savings, implementation in low and middle-income countries faces significant challenges. However, targeted approaches focusing on high-risk populations, integration with existing MCH services, and development of local guidelines can make preconception care a reality even in resource-limited settings.
The current practice of conducting risk assessments at the first antenatal visit represents a missed opportunity. True preconception care—delivered before pregnancy begins—has the potential to prevent many adverse outcomes and save both lives and resources. Developing and implementing local and national protocols should be a priority for improving maternal and child health outcomes in Ghana and other LMICs.
Preconception care is not a luxury—it is a fundamental component of comprehensive maternal and child health services that can transform outcomes for women and children worldwide.